Anders Perner: Clinical Trials

5 trials sponsored by Anders Perner, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 2 Phase 2, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 42Completed 1, Recruiting 1
Phase 31Completed 1

Follow Anders Perner: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Intensive Care Platform Trial
Albumin, No albumin use, LMWH in weight-adjusted dose - Intensive Care Patients, Intensive Care Unit Patients
Phase 4RecruitingAnders Perner100002025-06-262026-10-05
Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care
Isotonic crystalloids - Septic Shock, Sepsis
Phase 4CompletedAnders Perner1532014-09-012015-12-09
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis
Phase 2CompletedAnders Perner1002014-04-012016-09-30
Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
Ilomedin and Integrilin, low molecular weight heparin. - Pneumonia
Phase 2TerminatedThrombologic ApS52012-06-012016-04-22
Scandinavian Starch for Severe Sepsis/Septic Shock Trial
6% Hydroxyethyl starch 130/0.4, Ringers acetate - Severe Sepsis, Septic Shock
Phase 3CompletedAnders Perner8042009-12-012012-07-10

Conditions studied

Sepsis (2)  ·  Shock (2)  ·  Shock, Septic (2)  ·  Critical Illness (1)  ·  Fasciitis, Necrotizing (1)  ·  Fournier Gangrene (1)  ·  Gas Gangrene (1)  ·  Pneumonia (1)

Interventions

Heparin, Low-Molecular-Weight (2)  ·  Albumins (1)  ·  Eptifibatide (1)  ·  Hydroxyethyl Starch Derivatives (1)  ·  Immunoglobulin G (1)  ·  Immunoglobulins, Intravenous (1)  ·  LHFPL6 protein, human (1)  ·  Ringerfundin (1)  ·  Sodium Chloride (1)  ·  sterofundin (1)

Countries

Denmark (5)  ·  Finland (4)  ·  Iceland (2)  ·  Austria (1)  ·  Estonia (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Sweden (1)

Top investigators

Anders Granholm, MD (1)  ·  Morten H Moeller, Professor (1)  ·  Nicolai Haase, MD (1)

Results publications

PMID 22738085, PMID 24037226, PMID 24807084, PMID 25907781, PMID 27399982, PMID 27686349, PMID 28421246, PMID 31916575

NIH funding

2014 (1)